PCB39: Address of Justice Michael Kirby – HIV/AIDS & Solidarity – 30 Years On
On 7 December 2016, Justice Michael Kirby delivered the following keynote speech at the 39th Meeting of the UNAIDS Programme Coordinating Board during discussions on intellectual property and access to medicines. Justice Kirby served as a member of the United Nations Secretary-General’s High-Level Panel on Access to Medicines.
UNAIDS
PROGRAMME COORDINATING BOARD
39TH MEETING, WHO, GENEVA
AGENDA ITEM 6, 7 DECEMBER 2016HIV/AIDS & SOLIDARITY – 30 YEARS ON*
Michael Kirby**
PCB39: Eight hour drafting session charts future course for UNAIDS work program on Intellectual Property and the UN HLP
The Joint United Nations Programme on HIV/AIDS (UNAIDS) held the 39th Meeting of its Programme Coordinating Board (PCB) from 6-8 December 2016 in Geneva Switzerland. In his opening speech on Tuesday, 6 December 2016, Michel Sidibé (Executive Director, UNAIDS) paid tribute to the life of Australian national Katie Kirk – who passed away on 20 October 2016 while on mission in Indonesia.
In his speech, Sidibé noted:
PCB39: Statement of Knowledge Ecology International on Agenda item 6: UNAIDS synthesis report on IP
On Wednesday, 7 December 2016 Knowledge Ecology International (KEI) delivered the following statement at the 39th session of the UNAIDS Programme Coordinating Board (PCB) during discussions of agenda item 6 entitled, “Synthesis report of existing research and literature on intellectual property-related and other factors impacting the availability, affordability, and accessibility of treatment and diagnostics for HIV and co-infections in low and middle-income countries.”
UNAIDS PCB 39: Statement of India on the Executive Director’s Report to the 39th PCB
On Tuesday, 6 December 2016, the delegation of India delivered the following intervention at the 39th UNAIDS Programme Coordinating Board (PCB) Meeting.
India declared that she had “recently crossed the milestone of treating 1 million HIV patients with free Anti-Retroviral Therapy (ART).”
I will first briefly share efforts made by India to implement the Fast track Strategy. A number of major policy decisions have been taken recently towards achieving the 90-90-90 targets.
9 November 2016 – WTO TRIPS Council – Holy See’s statement on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, H.E. Archbishop Ivan Jurkovic, (Holy See) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines
Statement by H.E. Archbishop Ivan Jurkovic , Permanent Observer of the Holy See to the United Nations and Other International Organizations in Geneva at the World Trade Organization (WTO) Trade Related Intellectual Property Rights (TRIPs) Council, Geneva, 9 November 2016
Mr. President,
9 November 2016 – WTO TRIPS Council – UNCTAD’s statement on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, the United Nations Conference on Trade and Development (UNCTAD) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines. UNCTAD informed WTO members that the agency had recently recommended to Secretary-General Ban Ki-moon to consider endorsement of the Report of the High Level Panel.
9 November 2016 – WTO TRIPS Council – WHO’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, the World Health Organization (WHO) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
COUNCIL FOR TRIPS
8-9 NOVEMBER 2016
WHO STATEMENT
13. THE UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES
Thank you very much for giving WHO the opportunity to share our feedback on the Report of the High-Level Panel on Access to Medicines.
9 November 2016 – WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On 9 November 2016, the World Trade Organization’s (WTO) TRIPS Council held discussions on the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines (UN HLP). These timely WTO discussions on the UN HLP germinated from a 27 October 2016 request by Brazil, China, India and South Africa requesting the WTO Secretariat to place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.”
WTO TRIPS Council – Brazil, China, India and South Africa request discussion of the UN High-Level Panel on Access to Medicines
On Thursday, 27 October 2016, Brazil, China, India and South Africa submitted a communication (IP/C/W/619) to the World Trade Organization (WTO) requesting the WTO Secretariat to “place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.” In the WTO submission, Brazil, China, India and South Africa enclosed the entire Final Report of the UN Secretary-General’s High-Level Panel on Access to Continue Reading
17 October 2016: USTR Ambassador Michael Froman’s reflections on the United Nations High-Level Panel on Access to Medicines
On Monday morning, 17 October 2016, the United States Trade Representative, Michael Froman, delivered a lecture at the Graduate Institute entitled, The WTO in a Time of Change: Some Reflections.